BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Guo CY, Xu XF, Wu JY, Liu SF. PCR-SSCP-DNA sequencing method in detecting PTEN gene mutation and its significance in human gastric cancer. World J Gastroenterol 2008; 14(24): 3804-3811 [PMID: 18609703 DOI: 10.3748/wjg.14.3804]
URL: https://www.wjgnet.com/1007-9327/full/v14/i24/3804.htm
Number Citing Articles
1
Maisa Yoshimoto, Olga Ludkovski, Dave DeGrace, Julia L. Williams, Andrew Evans, Kanishka Sircar, Tarek A. Bismar, Paulo Nuin, Jeremy A. Squire. PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplicationsGenes, Chromosomes and Cancer 2012; 51(2): 149 doi: 10.1002/gcc.20939
2
Gang Li, Zhiguo Zhang, Jianghong Zhang, Tianbo Jin, Hongjuan Liang, Li Gong, Guangbin Cui, Haixia Yang, Shiming He, Yongsheng Zhang, Guodong Gao. Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature reviewDiagnostic Pathology 2014; 9(1) doi: 10.1186/1746-1596-9-17
3
Hasibe Cingilli Vural. PCR-SSCP-DNA Sequencing Method in DetectingPTENGene Mutation and its Significance in Human Breast Cancer in Turkish PopulationsBiotechnology & Biotechnological Equipment 2012; 26(5): 3220 doi: 10.5504/BBEQ.2012.0084
4
Asgar Ali, Pramod Kumar Mishra, Sadhana Sharma, Asit Arora, Sundeep Singh Saluja. Effects of PTEN gene alteration in patients with gallbladder cancerCancer Genetics 2015; 208(12): 587 doi: 10.1016/j.cancergen.2015.09.007
5
Sormeh Mina, Benjamin A Bohn, Ronald Simon, Antje Krohn, Matthias Reeh, Dirk Arnold, Carsten Bokemeyer, Guido Sauter, Jakob R Izbicki, Andreas Marx, Phillip R Stahl. PTEN deletion is rare but often homogeneous in gastric cancerJournal of Clinical Pathology 2012; 65(8): 693 doi: 10.1136/jclinpath-2011-200525
6
Saleh Azadbakht, Parastoo Baharvand, Mojgan Saki, Alireza Moayyedkazemi. Gastric Cancer: A Review of Risk Factors and New Insights into TreatmentCurrent Cancer Therapy Reviews 2023; 19(1): 19 doi: 10.2174/1573394718666220428105301
7
QIUFENG QI, YANG LING, MING ZHU, LINYAN ZHOU, MEIZHEN WAN, YANQING BAO, YONGPING LIU. Promoter region methylation and loss of protein expression of PTEN and significance in cervical cancerBiomedical Reports 2014; 2(5): 653 doi: 10.3892/br.2014.298
8
Emel Canbay, Ozlem T. Kahraman, Dursun Bugra, Burcu Caykara, M. Fatih Seyhan, Turker Bulut, Sumer Yamaner, Oguz Ozturk. Increased Gastric Cancer Risk withPTENIVS4 Polymorphism in a Turkish PopulationGenetic Testing and Molecular Biomarkers 2013; 17(3): 249 doi: 10.1089/gtmb.2012.0306
9
Roopma Wadhwa, Shumei Song, Ju-Seog Lee, Yixin Yao, Qingyi Wei, Jaffer A. Ajani. Gastric cancer—molecular and clinical dimensionsNature Reviews Clinical Oncology 2013; 10(11): 643 doi: 10.1038/nrclinonc.2013.170
10
Liang Yin, Yunzhao chen, Wenting Li, Benlin Hua, Jinfang Jiang, Hongan Li, Feng Li. Mutational analysis of the PTEN gene in soft tissue sarcomasThe Chinese-German Journal of Clinical Oncology 2010; 9(7): 422 doi: 10.1007/s10330-010-0647-9
11
Asgar Ali, Sundeep S. Saluja, Krishnan Hajela, Pramod K. Mishra, Moshahid A. Rizvi. Mutational and expressional analyses of PTEN gene in colorectal cancer from Northern IndiaMolecular Carcinogenesis 2014; 53(S1) doi: 10.1002/mc.22001
12
M. Moshahid Alam Rizvi, M. Shabbir Alam, Asgar Ali, Syed Jafar Mehdi, Swaraj Batra, A. K. Mandal. Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian populationJournal of Cancer Research and Clinical Oncology 2011; 137(8): 1255 doi: 10.1007/s00432-011-0994-0
13
Jing Shi, Yi-Ping Qu, Peng Hou. Pathogenetic mechanisms in gastric cancerWorld Journal of Gastroenterology 2014; 20(38): 13804-13819 doi: 10.3748/wjg.v20.i38.13804
14
MIN LI, HUAWEN SUN, LUJUN SONG, XIAODONG GAO, WENJU CHANG, XINYU QIN. Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinomaOncology Letters 2012; 4(6): 1213 doi: 10.3892/ol.2012.930
15
Guifang Du, Yanan Gu, Chengcheng Hao, Zhu Yuan, Junqi He, Wen G. Jiang, Shan Cheng. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancerOncotarget 2016; 7(20): 29440 doi: 10.18632/oncotarget.8751